Manning Paul B 4
4 · Candel Therapeutics, Inc. · Filed Jun 26, 2025
Insider Transaction Report
Form 4
Manning Paul B
Director
Transactions
- Award
Common Stock
2025-06-25$4.67/sh+1,070,663$4,999,996→ 2,213,069 total(indirect: By Trust)
Holdings
- 1,303,752(indirect: By LLC)
Common Stock
- 1,681,000
Common Stock
Footnotes (4)
- [F1]Represents shares acquired from the Issuer in a registered direct offering pursuant to the terms of a Securities Purchase Agreement dated as of June 23, 2025.
- [F2]The shares are held by The Paul B. Manning Revocable Trust dated May 10, 2000 (the "Trust"). The Reporting Person is the trustee of the Trust and has sole voting and investment power with respect to the shares held by the Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
- [F3]The shares are held directly by BKB Growth Investments, LLC ("BKB"). The Reporting Person is a co-manager of Tiger Lily Capital, LLC, the manager of BKB, and has shared voting and investment power with respect to the shares held by BKB. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
- [F4]Includes shares held jointly with spouse.